Company news

Scholar Rock Holding Corporation news in 2021

Scholar Rock Holding Corporation's news releases, calls and decks from 2021, newest first.

View company

Scholar Rock Announces Design of Phase 3 SAPPHIRE Clinical Trial Evaluating Apitegromab in Non-Ambulatory Patients with Type 2 and Type 3 Spinal Muscular Atrophy (SMA)

November 29, 2021

Scholar Rock Presents Data from Part A of the DRAGON Phase 1 Trial Evaluating SRK-181 as Monotherapy and in Combination with Anti-PD-(L)1 for the Treatment of Solid Tumors -- Announces Advancement into Part B

November 11, 2021

Scholar Rock Reports Third Quarter 2021 Financial Results and Highlights Business Progress

November 8, 2021

Scholar Rock to Present at Upcoming Healthcare Conferences

November 1, 2021

Scholar Rock to Present Apitegromab TOPAZ Phase 2 Pharmacologic Data at the 2021 World Congress of Neurology

October 2, 2021

Scholar Rock Presents Exploratory Responder Analysis on Efficacy Data from the Apitegromab TOPAZ Phase 2 Trial at the Child Neurology Society Annual Meeting

September 29, 2021

Scholar Rock Announces Issuance of U.S. Patent Protecting SRK-181, an Inhibitor of TGFβ1 Activation

September 27, 2021

Scholar Rock Presents Additional Data Analyses from the Apitegromab TOPAZ Phase 2 Trial at the World Muscle Society 2021 Virtual Congress

September 22, 2021

Scholar Rock to Present at the 2021 Cantor Virtual Global Healthcare Conference

September 21, 2021

Scholar Rock Appoints Caryn Parlavecchio as Chief Human Resources Officer

August 15, 2021

Scholar Rock Reports Second Quarter 2021 Financial Results and Highlights Business Progress

August 9, 2021

Scholar Rock to Present at the 2021 Wedbush PacGrow Healthcare Conference

August 4, 2021

Scholar Rock Announces Leadership Change

August 2, 2021

Scholar Rock to Present Apitegromab TOPAZ Phase 2 Trial Results Highlighting Pharmacokinetic (PK) and Pharmacodynamic (PD) Data at the 2021 European Academy of Neurology Congress

June 17, 2021

Scholar Rock Presents TOPAZ Phase 2 Data Showing the Transformative Potential of Apitegromab in Patients with Type 2 and 3 Spinal Muscular Atrophy (SMA) at the 2021 Virtual SMA Research & Clinical Care Meeting

June 10, 2021

Scholar Rock to Present Apitegromab Clinical Data from the TOPAZ Phase 2 Trial in Patients with Type 2 and 3 Spinal Muscular Atrophy at the 2021 Virtual SMA Research & Clinical Care Meeting

June 6, 2021

Scholar Rock to Present at Upcoming Healthcare Conferences in June

May 26, 2021

Scholar Rock Receives Fast Track Designation from the U.S. FDA for Apitegromab for the Treatment of Patients with Spinal Muscular Atrophy

May 23, 2021

Scholar Rock to Present Trials in Progress Poster for SRK-181 DRAGON Phase 1 Clinical Trial at the American Society of Clinical Oncology Annual Meeting

May 18, 2021

Scholar Rock Reports First Quarter 2021 Financial Results and Highlights Business Progress

May 12, 2021

Scholar Rock Announces Publication of Phase 1 Clinical Trial Data Evaluating Apitegromab in Healthy Volunteers in the Journal Advances in Therapy

May 10, 2021

Scholar Rock Announces Issuance of U.S. Patent Broadly Relevant to Inhibitors of Myostatin Activation

April 25, 2021

Scholar Rock Presents Biomarker Strategy to Support the SRK-181 DRAGON Phase 1 Proof-of-Concept Trial at the American Association for Cancer Research Annual Meeting

April 9, 2021

Scholar Rock Announces Positive 12-Month Top-Line Results From the TOPAZ Phase 2 Clinical Trial Evaluating Apitegromab in Patients With Type 2 and Type 3 Spinal Muscular Atrophy (SMA)

April 5, 2021

Scholar Rock Announces Publication of Preclinical Pharmacology, Pharmacokinetics, and Safety Profile of SRK-181 in the International Journal of Toxicology

March 21, 2021

Scholar Rock Announces the Addition of Joshua Reed to Its Board of Directors

March 17, 2021

Scholar Rock Announces Issuance of U.S. Patent Protecting Add-On or Combination Therapy with a Myostatin Inhibitor for the Treatment of Spinal Muscular Atrophy

March 16, 2021

Scholar Rock Presents TOPAZ Interim Analysis Data for Apitegromab in Spinal Muscular Atrophy at the 2021 Muscular Dystrophy Association (MDA) Virtual Clinical & Scientific Conference

March 14, 2021

Scholar Rock Reports Full Year 2020 Financial Results and Highlights Business Progress

March 8, 2021

Scholar Rock Announces Senior Management Promotions

February 3, 2021

Scholar Rock Presents Preclinical Data for SRK-181 at the TGFβ for Immuno-Oncology Drug Development Summit

January 26, 2021

Scholar Rock Provides Corporate Update and Highlights Priorities for 2021

January 10, 2021

Scholar Rock to Present at the 39th Annual J.P. Morgan Healthcare Conference

January 3, 2021

Decks in 2021